1. Home
  2. UG vs CCEL Comparison

UG vs CCEL Comparison

Compare UG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • CCEL
  • Stock Information
  • Founded
  • UG 1942
  • CCEL 1989
  • Country
  • UG United States
  • CCEL United States
  • Employees
  • UG N/A
  • CCEL N/A
  • Industry
  • UG Package Goods/Cosmetics
  • CCEL Managed Health Care
  • Sector
  • UG Consumer Discretionary
  • CCEL Health Care
  • Exchange
  • UG Nasdaq
  • CCEL Nasdaq
  • Market Cap
  • UG 36.4M
  • CCEL 34.8M
  • IPO Year
  • UG N/A
  • CCEL 1997
  • Fundamental
  • Price
  • UG $7.47
  • CCEL $4.57
  • Analyst Decision
  • UG
  • CCEL Hold
  • Analyst Count
  • UG 0
  • CCEL 1
  • Target Price
  • UG N/A
  • CCEL N/A
  • AVG Volume (30 Days)
  • UG 6.5K
  • CCEL 6.5K
  • Earning Date
  • UG 11-11-2025
  • CCEL 10-15-2025
  • Dividend Yield
  • UG 9.37%
  • CCEL 14.77%
  • EPS Growth
  • UG N/A
  • CCEL N/A
  • EPS
  • UG 0.56
  • CCEL N/A
  • Revenue
  • UG $10,856,174.00
  • CCEL $31,747,500.00
  • Revenue This Year
  • UG N/A
  • CCEL $1.75
  • Revenue Next Year
  • UG N/A
  • CCEL N/A
  • P/E Ratio
  • UG $13.03
  • CCEL N/A
  • Revenue Growth
  • UG N/A
  • CCEL N/A
  • 52 Week Low
  • UG $7.25
  • CCEL $4.09
  • 52 Week High
  • UG $14.15
  • CCEL $9.43
  • Technical
  • Relative Strength Index (RSI)
  • UG 46.05
  • CCEL 44.59
  • Support Level
  • UG $7.36
  • CCEL $4.35
  • Resistance Level
  • UG $7.70
  • CCEL $4.60
  • Average True Range (ATR)
  • UG 0.16
  • CCEL 0.14
  • MACD
  • UG -0.00
  • CCEL 0.00
  • Stochastic Oscillator
  • UG 49.11
  • CCEL 15.00

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: